一个更新的eumycetoma致病剂清单,以及它们在粒粒形成和治疗反应方面的差异
Wendy W J van de Sande1, Ahmed H Fahal2
1Department of Medical Microbiology and Infectious Diseases, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Clinical microbiology reviews
|May 1, 2024
概括
菌瘤是一种严重的真菌感染,具有许多致病剂,其中Madurella mycetomatis是最常见的. 需要进行研究,以了解真菌病原体的变异,并改善治疗结果.
科学领域:
- 菌类学 菌类学是指菌类学.
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 世界卫生组织 (WHO) 现在已将Eumycetoma致病原体认定为优先级的真菌病原体.
- 对这些药物,它们的临床变异和治疗反应缺乏全面的了解.
- 由于它们对健康的重大影响,真菌优先病原体需要进一步调查.
研究的目的:
- 审查已识别的导致eumycetoma的真菌物种.
- 分析临床表现的变化,瘤粒形成和抗真菌易感性.
- 评估当前了解和治疗eumycetoma的知识差距和挑战.
主要方法:
- 对12379例eumycetoma病例进行了系统审查.
- 使用传统方法 (培养,组织学) 和分子工具识别真菌病原体.
- 对临床数据的分析,包括病变的外观,粒状特征和治疗反应.
主要成果:
- 69种不同的真菌物种被确定为eumycetoma病原体,其中Madurella mycetomatis是最常见的.
- 分子识别工具揭示了新的致病原体.
- 观察到瘤粒形成和抗真菌敏感性的变化,尽管病变外观没有显示差异.
- 有限的数据表明,Fusarium物种可能对治疗的反应不如Madurella mycetomatis.
结论:
- 尽管世卫组织承认,但真菌eumycetoma剂的多样性需要进一步研究.
- 分子方法对于准确识别致病真菌至关重要.
- 了解抗真菌敏感性和临床结果的变化对于有效的治疗策略至关重要.
- 需要进行大型临床试验,以克服包括手术在内的当前治疗模式带来的挑战.
关键词:
生物膜是一种生物膜.诊断 诊断 诊断 诊断 诊断 诊断谷物 谷物 谷物 谷物这是伊特拉可纳.分子诊断 分子诊断 分子诊断这就是我的mycetomacetoma.被忽视的热带疾病易感性 易感性 易感性更多相关视频
08:45Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
13.8K
06:58Author Spotlight: Evaluation of Entomopathogenic Fungi in Wild Monochamus alternatus Populations for Biocontrol Applications in Forest Wood Borers
Published on: September 29, 2023
719
相关概念视频
01:28Fungal Phylum Microsporidia
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...